Amarin Corp Plc (AMRN)

[HDGabor]

r-

do you have the TG reduction numbers, V vs L? I can't look it up now but if I remember correctly, it's something like 33% vs 40%?

If so, how is this even debatable, when the 33% one (V) also reduces CVD and the 40% one (L) increases LDL and interferes with EPA's benefit (Viet Le's embargoed presentation).

If we just look at one thing only, TG, then yes Lovaza wins out. But nothing is ever that simple, we shouldn't ignore everything else.

Against baseline -44.9% vs -27%, against placebo -51.6% vs -33%. I leave it for professionals but - my view only - in case of TG >500, the TG reduction outweighs the risk of everything else.

Best,
G